Global the first human the intersection of embryo and stem

Global the first human the intersection of embryo and stem cell clinical trial because costly to ask, park
The core is pointed out: Get approval of official side and carry on the outstanding dragon (Geron) of U.S.A. of the first human embryo's stem cell's clinical trial in the world The biological pharmaceuticals declared a few days ago, because the necessary fee has been used high, they had already decided to stop this test.

According to report of November 15 of Britain " Daily Telegraph ", get approval of official side and carry on the outstanding dragon (Geron) of U.S.A. of the first human embryo's stem cell's clinical trial in the world The biological pharmaceuticals declared a few days ago, because the necessary fee has been used high, they had already decided to stop this test. This decision initiates the dissatisfaction of the group and individual that charity organization,etc. hopes to profit from research at once.

The outstanding dragon's company says, after carrying on the strategy assessment to the human embryo's clinical experimentation cost of stem cell, they determine, stop 0.5 tablet type research project Cheng these. This general headquarters lie in front of this of company of California and get approval of federal medicine administration bureau of U.S.A. for the first time, injure patients and carry on the stem cell and treat the clinical trial to the spinal, the test begins with October of 2010, already 4 patients have accepted so far that test the treatment.

The outstanding dragon's company claims, stop this tested and had nothing to do with the safe problem and and because lack fund and " it is too complicated to supervise " . They will no longer recruit the new test patient, but have finished and already accepted the treatment of the patient that test to those, each of these patients has all injected 2 million cells. Hereafter, the outstanding dragon's company will turn to the cancer medicine and study especially.

The decision of the outstanding dragon's company makes a lot of feel angry about this personage whose research is full of expectation. Devoted to the intersection of subsidy and spinal it injures Chris studied to treat to be many with the intersection of Dana and the intersection of Lievres and foundation Directors Daniel stop graceful (DanielHeumann)s Say: "I feel angry, they have given people hope, but stop on the grounds of financial problem, this is base, they treat us just as treat the little white mouse. "

Support the person whose treatment studies of stem cell of embryo to believe, this kind of treatment will be treating respects such as senile dementia, Parkinson disease, heart disease and apoplexy,etc. and making the great breakthrough, even help patients in the following a certain days " Change " Organ tissue damaged.



Global the first human the intersection of embryo and stem cell clinical trial because costly to ask, park